The Detroit Medical Center is a for-profit alliance of hospitals that encompasses over 2,000 licensed beds, 3,000 affiliated physicians and over 12,000 employees. Located in Midtown Detroit, the DMC is affiliated with medical schools from Wayne State University and Michigan State University.

During the past decade, Detroit Receiving Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Detroit Receiving Hospital" #1 sponsor was "Wayne State University" with 5 trials, followed by "University of Michigan" with 4 trials sponsored, "Indiana University" with 2 trials sponsored, "Neuren Pharmaceuticals Limited" with 2 trials sponsored and "University of Virginia" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Detroit Receiving Hospital" #1 collaborator was "Medical University of South Carolina" with 11 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 5 trials as a collaborator, "University of Cincinnati" with 3 trials as a collaborator and "Wayne State University" with 3 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Detroit Receiving Hospital" are "Heart Failure" (4 trials), "Stroke" (4 trials), "Traumatic Brain Injury" (4 trials), "Sepsis" (3 trials) and "Severe Sepsis" (3 trials). Many other conditions were trialed in "Detroit Receiving Hospital" in a lesser frequency.

Most popular intervention types in "Detroit Receiving Hospital" are "Drug" (20 trials), "Device" (8 trials), "Other" (7 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aspirin" (2 trials), "NNZ-2566" (2 trials), "Saline" (2 trials) and "Usual Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Detroit Receiving Hospital" are 44 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Detroit Receiving Hospital". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Detroit Receiving Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Detroit Receiving Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".